Kaiser Foundation Health Plan Northern California |
Lenvima (14 MG Daily Dose) (lenvatinib) |
Drugs for Cancer : Drugs for Cancer |
- Neuroendocrine Tumor (NET):
Duration: 1 year(s)
Documented Diagnosis: Yes
Medical Test Required: No
Reauthorization Required: No
Duration of Reauthorization: N/A
- May be covered under Medical Benefit.
|